Literature DB >> 18346877

Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity.

M Wenghoefer1, A Pantelis, H Dommisch, R Reich, M Martini, J-P Allam, N Novak, S Bergé, S Jepsen, J Winter.   

Abstract

The aim of this study was to investigate the gene expression of human beta-defensin-1, -2, -3 (hBD-1, -2, -3), interleukin-1beta, tumour necrosis factor-alpha and cyclooxygenase-2 in oral squamous cell carcinoma (OSCC) compared to benign and premalignant lesions as well as healthy controls. Biopsies of healthy gingiva (n=5), irritation fibroma (n=5), leukoplakia (n=5) and OSCC (n=5) were obtained during routine surgical procedures. RNA was extracted according to standard protocols and transcripts of hBD-1, -2, -3, interleukin-1beta, tumour necrosis factor-alpha and cyclooxygenase-2 were analysed by real-time polymerase chain reaction. The expression of hBD-1 was reduced in all lesions (5-fold in irritation fibroma and 2.5-fold in leukoplakia), but most significantly (50-fold) in OSCC. hBD-1 appears to play a role in the development of OSCC. The loss of its function might contribute to the malignant progression of these tumours.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346877     DOI: 10.1016/j.ijom.2008.02.003

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  16 in total

1.  Oral pathogens change proliferation properties of oral tumor cells by affecting gene expression of human defensins.

Authors:  T Hoppe; D Kraus; N Novak; R Probstmeier; M Frentzen; M Wenghoefer; S Jepsen; J Winter
Journal:  Tumour Biol       Date:  2016-08-01

2.  Oncogenic relevant defensins: expression pattern and proliferation characteristics of human tumor cell lines.

Authors:  Jochen Winter; Dominik Kraus; Jan Reckenbeil; Rainer Probstmeier
Journal:  Tumour Biol       Date:  2015-12-28

3.  Glucocorticoid receptor regulates overlapping and differential gene subsets in developing and adult skin.

Authors:  Lisa M Sevilla; Pilar Bayo; Víctor Latorre; Ana Sanchis; Paloma Pérez
Journal:  Mol Endocrinol       Date:  2010-09-29

Review 4.  Beta-defensins: what are they really doing in the oral cavity?

Authors:  G Diamond; Lk Ryan
Journal:  Oral Dis       Date:  2011-02-18       Impact factor: 3.511

5.  NOD1, RIP2 and Caspase12 are potentially novel biomarkers for oral squamous cell carcinoma development and progression.

Authors:  Xiang Wang; Wenhui Jiang; Ning Duan; Yajie Qian; Qian Zhou; Pei Ye; Hongliu Jiang; Yang Bai; Weiyun Zhang; Wenmei Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 6.  Alarmins and immunity.

Authors:  Zhen Han; Joost J Oppenheim
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

7.  Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.

Authors:  Jochen Winter; Annette Pantelis; Dominik Kraus; Jan Reckenbeil; Rudolf Reich; Soeren Jepsen; Hans-Peter Fischer; Jean-Pierre Allam; Natalija Novak; Matthias Wenghoefer
Journal:  BMC Cancer       Date:  2012-10-11       Impact factor: 4.430

8.  Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study.

Authors:  Philipp Stockmann; Falk Wehrhan; Stephan Schwarz-Furlan; Florian Stelzle; Susanne Trabert; Friedrich W Neukam; Emeka Nkenke
Journal:  J Transl Med       Date:  2011-08-15       Impact factor: 5.531

9.  Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patients.

Authors:  Qi Han; Ruinan Wang; Chongkui Sun; Xin Jin; Dongjuan Liu; Xin Zhao; Lili Wang; Ning Ji; Jing Li; Yu Zhou; Ling Ye; Xinhua Liang; Lu Jiang; Ga Liao; Hongxia Dan; Xin Zeng; Qianming Chen
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  Nuclear hBD-1 accumulation in malignant salivary gland tumours.

Authors:  M Wenghoefer; A Pantelis; H Dommisch; W Götz; R Reich; S Bergé; M Martini; J P Allam; S Jepsen; S Merkelbach-Bruse; H P Fischer; N Novak; J Winter
Journal:  BMC Cancer       Date:  2008-10-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.